Inventiva publishes presentation on lanifibranor's antifibrotic effects in preclinical models

Inventiva published a medical research presentation showing that investigational lanifibranor reduced liver fibrosis across preclinical models. The findings support further development of the drug as an antifibrotic therapy for MASH.